coiaward2010

Webinar: GENERIC TKIs IN CML

The Glivec patent expires in most countries latest on 21 Dec 2016.

The CML Advocates Network has been following the situation of TKI generics closely for 3 years, and has now provided a webinar which summarizes the current status.

This webinar answers some important questions, such as:

  • What are generics, and do they differentiate from innovator products?
  • Which generics of CML Tyrosine Kinase Inhibitors exist?
  • What do we know about efficacy and safety?
  • What information on CML generics is available to patients?
  • What has the patient advocacy community done so far?
  • What can patients and patient advocacy groups do about CML generics?

More can be found on our CML Advocates Network Knowledge Base on CML Generics at http://www.cmladvocates.net/generics.

If you want access to the slides, please contact Jan Geissler at .

Webstream via AuthorStream (allows to skip slides)

 

 

 

 

 

 

 

 

webinar


Olga Lucia Jimenez Community Builder Avatar   15.12.2016 (12:20:48)
Generic drugs for cml Yes No Would like to have access to the webinar
 
 
   
 

Please donate!

Please donate!

LogIn

Tweet Feed

cmlnet
Just a week to meet you at #patient #advocacy Conference #CMLHZ17 Don't forget to bring your printed poster with yo… twitter.com/i/web/status/8…

Friday, 19 May 2017

cmlnet
@ZPWLC @LeukaemiaCAREuk Looking forward to meet all the #cml #advocates to #learnsharegrow with you Zack! #cmlHZ17… twitter.com/i/web/status/8…

Thursday, 18 May 2017 in reply to ZPWLC

ZPWLC
Only one week to go until #CML Horizons! Looking forward to catching up on all things #CML #advoacy #CMLHZ17… twitter.com/i/web/status/8…

Retweeted Thursday, 18 May 2017